News

Digital pathology services leader Flagship Biosciences announces the launch of a novel approach for quantitative measurement of multiple tissue biomarkers called FACTS (Feature Analysis on Consecutive Tissue Sections). Flagstaff, AZ – Oct. 20, 2010. Flagship Biosciences announced today the launch of a new tissue biomarker multiplexing analytical tool for tumors and other tissues. The patent […]

European technology leader in histoinformatics™ and American digital pathology services firm announce a partnership for delivering quantitative results faster to pharmaceutical and medical device customers Flagstaff, AZ – Sept 17, 2010. In recognition of the opportunities in Histoinformatics™, covering whole slide stereology and whole slide tissue pattern recognition for improving the measurement of efficacy and […]

New office offers local access for Cambridge biotech companies to pathologist, technician, scanning and image analysis Flagstaff, AZ – September 13, 2010 – Flagship Biosciences LLC, a provider of digital pathology services, has opened a local digital pathology office in the Boston suburbs to better support the growing demand for local quantitative histopathology services. The office is […]

Scientific Advisory Board to help drive pathology innovation in preclinical toxicology and oncology clinical trials Flagstaff, AZ – August 26, 2010 – Flagship Biosciences LLC, a provider of digital pathology services, has formed a Scientific Advisory Board composed of experienced leaders in the pharmaceutical industry. Flagship is a pathologist-owned company committed to improving the use of digital […]

CISH (Chromogenic In-Situ Hybridization) is a new technique first published by Tanner and his collegues (Am J Pathol 2000, 157:1467-1472). It will likely prove to be much more economical than FISH (FISH can range up to ten times the cost of IHC), and can be conducted with an ordinary microscope. Because it is chromogenic, the […]

Partnership with PrognosDx offers tissue-based, global patterns of histone modification patient profiling for use in early stage drug discovery and various phases of clinical trials. Flagstaff, AZ – July 19, 2010 – Flagship Biosciences LLC, a provider of digital pathology services, announced today an exclusive partnership with PrognosDx Health to provide pharmaceutical companies and cancer centers […]

Partnership with Vitro Molecular in histology and image analysis IHC biomarker development offers a complete companion diagnostics development service Flagstaff, AZ – July 5, 2010 – Flagship Biosciences LLC, a provider of digital pathology services, announced it has expanded its partnership with Vitro Molecular in Miami Florida to provide validated IHC companion diagnostic development capabilities. […]

Image analysis experts and board-certified pathologists team up to offer on-line digital pathology training in image analysis Flagstaff, AZ – June 5, 2010 – Flagship Biosciences LLC, a provider of digital pathology services, launches on-line training program for image analysis in digital pathology. The first course is a once a week six-week series and is designed to […]

Below is an example of how histology pattern recognition can be used  to determine thymic cortex to medulla ratios. The rat thymus was initially stained with classic H&E and then analyzed with image analysis tools. Below is the results with histology pattern recognition. By performing image analysis on a whole image slide of a rat […]

Industry veteran joins digital pathology services company Flagstaff Biosciences as CEO. Flagstaff, AZ – May 22, 2010 – Flagship Biosciences LLC, a provider of digital pathology services, announced that Steven Potts has joined the company as Chief Executive Officer, with Dave Young continuing to serve as President of Flagship Biosciences. Steve has extensive experience in digital pathology, […]